Show simple item record

dc.contributor.authorPreston, Mark A.
dc.contributor.authorWilson, Kathryn
dc.contributor.authorMarkt, Sarah C.
dc.contributor.authorGe, Rongbin
dc.contributor.authorMorash, Christopher
dc.contributor.authorStampfer, Meir
dc.contributor.authorLoda, Massimo F.
dc.contributor.authorGiovannucci, Edward
dc.contributor.authorMucci, Lorelei A.
dc.contributor.authorOlumi, Aria F.
dc.date.accessioned2019-09-05T17:04:33Z
dc.date.issued2014
dc.identifier.citationPreston, Mark A., Kathryn M. Wilson, Sarah C. Markt, Rongbin Ge, Christopher Morash, Meir J. Stampfer, Massimo Loda, Edward Giovannucci, Lorelei A. Mucci, and Aria F. Olumi. 2014. “5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.” JAMA Internal Medicine 174 (8): 1301. https://doi.org/10.1001/jamainternmed.2014.1600.
dc.identifier.issn2168-6106
dc.identifier.issn2168-6114
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41292549*
dc.language.isoen_US
dc.publisherAmerican Medical Association
dash.licenseOAP
dc.title5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate Cancer
dc.typeJournal Article
dc.description.versionAccepted Manuscript
dc.relation.journalJAMA Internal Medicine
dash.depositing.authorStampfer, Meir
dc.date.available2019-09-05T17:04:33Z
dash.workflow.comments1Science Serial ID 49930
dc.identifier.doi10.1001/jamainternmed.2014.1600
dash.source.volume174;8
dash.source.page1301
dash.contributor.affiliatedStampfer, Meir


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record